308 lines
7.2 KiB
Plaintext
308 lines
7.2 KiB
Plaintext
|
English French Notes Complete/Exclude
|
||
|
BURNING ON URINATION:
|
||
|
LOW RED BLOOD COUNT:
|
||
|
KIDNEY PROBLEMS:
|
||
|
Females Only:
|
||
|
PREGNANT:
|
||
|
Males Only:
|
||
|
DISCHARGE FROM PENIS:
|
||
|
IMPOTENCE:
|
||
|
OTHER:
|
||
|
RASH/ULCERS ON PENIS:
|
||
|
PATIENT LABORATORY INFORMATION
|
||
|
Aldolase
|
||
|
Anti-DNA Antibody
|
||
|
Anti-skeletal muscle
|
||
|
Alkaline phosphatase
|
||
|
Anti-RNP
|
||
|
Urea nitrogen
|
||
|
Hepatitis B Antibody
|
||
|
Hepatitis B Antigen
|
||
|
Cholesterol
|
||
|
Complement CH50
|
||
|
Cryoglobulins
|
||
|
Creatinine
|
||
|
Complement
|
||
|
Glucose
|
||
|
Complement C4
|
||
|
HLA B27
|
||
|
Bilirubin, total
|
||
|
Latex fixation
|
||
|
Protein, total
|
||
|
Uric acid
|
||
|
Salicylate
|
||
|
UR Glucose
|
||
|
UR Protein
|
||
|
RBC/HPF
|
||
|
WBC/HPF
|
||
|
Granular/cast/lpf
|
||
|
Choloride
|
||
|
WBC/CASTS/LPF
|
||
|
Bicarbonate
|
||
|
Creatinine Clearance
|
||
|
Neutrophil
|
||
|
Bands
|
||
|
Lymphs
|
||
|
Monocytes
|
||
|
Eosino
|
||
|
Baso
|
||
|
Platelet
|
||
|
Reticulocytes
|
||
|
Westergren ESR
|
||
|
Protrhombin time
|
||
|
Partial thromboplastin
|
||
|
NARRATIVE HISTORY
|
||
|
Physical Examination
|
||
|
General:
|
||
|
LYMPH NODE ENLARGEMENT:
|
||
|
UVEITIS/IRITIS:
|
||
|
MUSCLE TENDERNESS:
|
||
|
CONJUNCTIVITIS/EPISCLERITIS:
|
||
|
MUSCLE WEAKNESS-DISTAL:
|
||
|
CATARACT:
|
||
|
MUSCLE WEAKNESS-PROXIMAL:
|
||
|
ORAL ULCERS:
|
||
|
MUSCLE ATROPHY
|
||
|
RALES:
|
||
|
PSYCHOSIS:
|
||
|
PLEURAL RUB/
|
||
|
CLINICAL PLEURISY:
|
||
|
ORGANIC BRAIN SYNDROME:
|
||
|
PLEURAL EFFUSION:
|
||
|
MOTOR NEUROPATHY:
|
||
|
PERICARDIAL RUB/PERICARDITIS:
|
||
|
SENSORY NEUROPATHY:
|
||
|
CUTANEOUS VASCULTITIS:
|
||
|
RASH-MALAR:
|
||
|
PALPABLE PUPURA:
|
||
|
RASH-DISCOID:
|
||
|
SKIN ULCERS:
|
||
|
RASH-JRA:
|
||
|
ERYTHEMA NODOSUM:
|
||
|
RASH-SLE,NON-MALAR:
|
||
|
PERIUNGAL ERYTHEMA:
|
||
|
RASH-OTHER:
|
||
|
HELIOTROPE EYELIDS:
|
||
|
KNUCKLE ERYTHEMA:
|
||
|
TELANGIECTASIS:
|
||
|
SUBCUTANEOUS CALCIFICATIONS:
|
||
|
SCLERODACTYLY:
|
||
|
KERATODERMIA BLENNORRHAGICA:
|
||
|
SCLERODERMA-EXTREMITY:
|
||
|
DACTYLITIS:
|
||
|
SCLERODERMA-GENERALIZED:
|
||
|
NAIL PITTING:
|
||
|
MORPHEA:
|
||
|
PSORIASIS:
|
||
|
DIGITAL ULCERS:
|
||
|
HEEL PAIN:
|
||
|
HEALTH ASSESSMENT
|
||
|
Questionnaire date:
|
||
|
Study status:
|
||
|
Drug Study:
|
||
|
Dressing and Grooming:
|
||
|
Arising:
|
||
|
Eating:
|
||
|
Walking:
|
||
|
Hygiene:
|
||
|
Reach:
|
||
|
Activities:
|
||
|
Pain Scale:
|
||
|
II. CLINICAL DATA
|
||
|
Sex
|
||
|
Age
|
||
|
NYHA functional class
|
||
|
Creatinine
|
||
|
III. CARDIAC CATHETERIZATION AND ANGIOGRAPHIC DATA
|
||
|
LVEDP
|
||
|
Lv Contraction Score (from contrast or
|
||
|
Aortic systolic pressure
|
||
|
radionuclide angiogram or 2D echo)
|
||
|
*PA systolic pressure
|
||
|
*PAW mean pressure
|
||
|
Grade Ejection Fraction Definition
|
||
|
*patients having right heart cath.
|
||
|
Range
|
||
|
Percent left main stenosis
|
||
|
Number of other major coronary
|
||
|
arteries (LAD,right with PDA,
|
||
|
circumflex with marginals)
|
||
|
with stenosis(es) => 50%
|
||
|
IV. OPERATIVE RISK SUMMARY DATA
|
||
|
Physician's preoperative
|
||
|
estimate of operative
|
||
|
V. OPERATIVE DATA
|
||
|
CABG distal anastomoses:
|
||
|
number with vein
|
||
|
number with IMA
|
||
|
Great vessel repair requiring
|
||
|
Other(not checked above)
|
||
|
Date of death
|
||
|
Renal failure requiring
|
||
|
Repeat cardiopulmonary
|
||
|
Repeat Cardiopulmonary
|
||
|
TIME TEST:
|
||
|
AGE:
|
||
|
WT LBS:
|
||
|
REF PHYS:
|
||
|
ETT PROTOCOL:
|
||
|
HYPERVENTILATION:
|
||
|
TARGET HR:
|
||
|
RESTING EKG:
|
||
|
ONSET CP
|
||
|
PEAK EX
|
||
|
SBP/DBP
|
||
|
ST/SLP
|
||
|
RPP/1000
|
||
|
MIN:SEC
|
||
|
PEAK MPH:
|
||
|
% TARGET HR:
|
||
|
TIME ST SEGMENT RETURN TO BASELINE:
|
||
|
SIGNIFICANT ARRHYTHMIAS:
|
||
|
BLOOD PRESSURE CHANGES:
|
||
|
OTHER EKG CHANGES:
|
||
|
COMPLICATIONS:
|
||
|
EKG TECH:
|
||
|
ATTN PHYS:
|
||
|
-------------------------------VENTRICULAR STUDY----------------------------
|
||
|
PREMEDICATION:
|
||
|
RECORDING SITE SITE:
|
||
|
VENTRICULAR THRESHOLD (mA):
|
||
|
REPETITIVE RESPONSES
|
||
|
VENT. EFF. REFR. PERIOD
|
||
|
BURST PACING (# REP. RESPONSES):
|
||
|
SHORTEST BURST CL:
|
||
|
INITIATION SEQUENCE OF V-T:
|
||
|
DURATION OF V-T/V-F:
|
||
|
V-T CYCLE LENGTH:
|
||
|
AXIS:
|
||
|
TERMINATION OF VT:
|
||
|
PACE OUT CYCLE LENGTH OF V-T:
|
||
|
CARDIOVERSION (J):
|
||
|
RHYTHM:
|
||
|
MEDICATIONS ON DISCHARGE:
|
||
|
CATHETERIZATION REPORT
|
||
|
ECHO REPORT
|
||
|
ECG REPORT
|
||
|
EP REPORT
|
||
|
HOLTER REPORT
|
||
|
RHEUMATOLOGY REPORT
|
||
|
ETT REPORT
|
||
|
Enter patient name or the date & time:
|
||
|
Pg.
|
||
|
CONFIDENTIAL
|
||
|
PROCEDURE DATE/TIME:
|
||
|
Select Patient Name or Date of Procedure to Delete:
|
||
|
ARE YOU SURE YOU WANT TO DELETE
|
||
|
Procedure Deleted
|
||
|
A-LEAD REPORT
|
||
|
V-LEAD REPORT
|
||
|
GENERATOR IMPLANT REPORT
|
||
|
PACEMAKER SURVEILLANCE REPORT
|
||
|
COMBINED IMPLANT/LEADS PROCEDURES
|
||
|
Enter Patient name or Date of Generator Implant:
|
||
|
Generator Information....
|
||
|
Atrial Lead Data....
|
||
|
Ventricular Lead Data...
|
||
|
GENERATOR DATA...
|
||
|
Ventricular
|
||
|
Atrial
|
||
|
Lead data entered for this patient
|
||
|
Lead implanted on
|
||
|
DEMOGRAPHIC INFORMATION
|
||
|
ACTIVE PATIENT LIST
|
||
|
This report has been set up to print with a line length of 132
|
||
|
characters. Select a device that uses a 132 character line length.
|
||
|
<RETURN> to continue
|
||
|
PACEMAKER ACTIVE PATIENT LIST
|
||
|
<RETURN> to Continue
|
||
|
EAST PSC FOLLOW-UP
|
||
|
REGISTRY ONLY
|
||
|
WEST PSC FOLLOW-UP
|
||
|
Pg.
|
||
|
GENERATOR IMPLANT DATA
|
||
|
V AND A LEAD IMPLANT DATA
|
||
|
MFR MODEL
|
||
|
SER. NO.
|
||
|
Enter Patient Name, or Date and Time:
|
||
|
SURVEILLANCE PROCEDURES
|
||
|
*** SCREEN EDIT ***
|
||
|
*** BRIEF EDIT ***
|
||
|
MCAR(698
|
||
|
TYPE OF LEAD NOT DEFINED FOR THIS PATIENT IN GENERATOR FILE
|
||
|
PRESS RETURN TO CONTINUE:
|
||
|
PACEMAKER SURVEILLANCE
|
||
|
PATIENT HAS NO CURRENT GENERATOR IMPLANT LISTED IN GENERATOR FILE
|
||
|
Entry Deleted
|
||
|
FORM TRANSFER TO NATIONAL CENTER
|
||
|
Select Reason for Transmission of this Report:
|
||
|
Transfer Report to :
|
||
|
WESTERN PACEMAKER CENTER
|
||
|
EASTERN PACEMAKER CENTER
|
||
|
Answer with 'E' for Eastern Center,'W' for Western Center, or 'B' for Both
|
||
|
BOTH EASTERN AND WESTERN PACEMAKER CENTERS
|
||
|
TRANSMIT REPORT
|
||
|
MCR(
|
||
|
PACEMAKER REPORT TRANSMISSION
|
||
|
PACEMAKER CENTER REPORT
|
||
|
REGISTRATION FORM DATA
|
||
|
REASON(S) FOR REPORT:
|
||
|
TELEPHONE FOLLOW-UP PROVIDED BY:
|
||
|
EASTERN PACEMAKER SURVEILLANCE CENTER
|
||
|
WESTERN PACEMAKER SURVEILLANCE CENTER
|
||
|
LOCAL VAMC
|
||
|
PULSE GENERATOR
|
||
|
MFR:
|
||
|
BEGINNING OF LIFE MAGNET RATE:
|
||
|
END OF LIFE MAGNET RATE:
|
||
|
TELEPHONES:
|
||
|
IMPLANTING HOSPITAL:
|
||
|
HOME:
|
||
|
WORK:
|
||
|
DATE OF INITIAL IMPLANT:
|
||
|
RESPONSIBLE PHYSICIAN:
|
||
|
MCPHYS(
|
||
|
PULSE GENERATORS INCLUDING PRESENT:
|
||
|
ATRIAL LEAD
|
||
|
VENTRICULAR LEAD
|
||
|
ATRIAL LEAD
|
||
|
MODEL #:
|
||
|
SERIAL #:
|
||
|
DATE:
|
||
|
PART 2
|
||
|
ALTERNATE CONTACT
|
||
|
ALTERNATE CONTACT ADDRESS
|
||
|
TELEPHONE TRANSMITTER:
|
||
|
MODEL #:
|
||
|
IMPLANT PARAMETERS: ATRIAL LEAD
|
||
|
THRESHOLD IN VOLTS
|
||
|
THRESHOLD IN MAs
|
||
|
AT .5 MS PW
|
||
|
RESISTANCE AT 5 VOLTS
|
||
|
R-WAVE OR P-WAVE
|
||
|
PSA USED:
|
||
|
SURVEILLANCE DATA
|
||
|
PROGRAMMED SETTINGS
|
||
|
PULSE WIDTH
|
||
|
AMPLITUDE
|
||
|
SENSITIVITY
|
||
|
REFRACTORY PERIOD
|
||
|
LOWER RATE LIMIT:
|
||
|
UPPER RATE LIMIT:
|
||
|
PACING MODE:
|
||
|
CLINIC MEASUREMENTS
|
||
|
PULSE WIDTH
|
||
|
AMPLITUDE
|
||
|
RATIO (T/L)
|
||
|
THRESHOLD WIDTH
|
||
|
THRESHOLD AMPLITUDE
|
||
|
CAPTURE
|
||
|
SENSE
|
||
|
RATE NO MAGNET:
|
||
|
RATE MAGNET:
|
||
|
#################### #################### ####################
|
||
|
#################### #################### ####################
|
||
|
#################### #################### ####################
|
||
|
#################### #################### ####################
|
||
|
#################### #################### ####################
|